Rating: Neutral (Avoid, Wait for Pullback) | Target Price: RMB 17.4–19.7 | Current Price: RMB 22.25 (close, 2026-10-28) | Market Cap: approx. RMB 172.6 billion (estimate: RMB 22.25 × 7.757 billion shares) | Margin of Safety: -21.8% (price above base-case fair value; no margin of safety) | Probability-Weighted Fair Value: RMB 19.03 (expected return approx. -14.5%) | Time Horizon: 6–12 months | Report Date: 2026-10-28
CSC Financial is a top-tier brokerage with first-class fundamentals: in the first three quarters of 2026, it underwrote RMB 37.607 billion of IPOs, a 17.39% share, rising to No. 2 in the industry; FY2025 weighted ROE of 10.51% (estimated) ranks in the top tier among leading brokerages; Beijing Financial Holdings and Central Huijin together hold 66.6% of shares, with a solid capital and shareholder structure. However, the core judgment of this report is: the current price of RMB 22.25 has essentially capitalized the 2026 bull-market earnings run-rate as if perpetual — PB-ROE reverse solving implies the market is pricing in a sustainable ROE of about 17%, whereas the company's through-cycle ROE center is only 8.5%–10% and the industry's normalized level is 7%–8%; the H shares of the same asset trade at only 0.80x PB (A/H discount of about 60%), the most honest benchmark against the A-share premium. Hard trading-volume data is already falling (margin financing down about 19% from its RMB 3 trillion peak; September average daily turnover -15.7% MoM). We forecast 2027 net profit attributable to parent falling from RMB 12.4–13.4 billion in 2026 to RMB 11.0–12.4 billion. The base-case fair value range is RMB 17.4–19.7; the current price is about 20% above the base-case midpoint — downside to the base-case midpoint about -16.6%, to the bear-case midpoint about -31%, while upside to the bull-case midpoint is only +15.7% — the risk/reward is asymmetrically skewed downward. Good company, expensive price; we recommend avoiding and waiting for a pullback into the fair-value range or a reversal signal in trading volume.
Evidence grade B (primarily first-hand financial statements and announcements; event and expectation-gap portions rely partly on external data). Market environment: headwind — equity-market conditions are cooling marginally from highs; of the three condition indicators, margin financing and turnover have already fallen from their year-to-date peaks, with only IPOs still on an uptrend.
Most likely changes over the next 6–12 months (relative to the status quo):
Primary share-price driver: market trading volume (average daily stock-and-fund turnover × margin balance) — it simultaneously determines earnings across brokerage, margin financing, and proprietary trading, and the survival of the PB premium. Verifiable expectation gap: A-share sell-side consensus 2026E EPS of RMB 1.63 (net profit approx. RMB 13.68 billion), 2027E flat (-1.8%); our 2026E is 2%–9% lower and 2027E 8%–18% lower — the disagreement lies in the slope of volume cooling from Q4 onward. Note that the anchor for this expectation gap is thin (target-price sample is 0, earnings forecast sample only 3–4, revised down -1.3% over the past 90 days), and the overseas aggregate target price (mean RMB 30.80, sample of 3 analysts) points the opposite way — with divergent anchors, one should not bet heavily on a single direction. Validation/falsification: see the tracking checklist in Chapter XII (Q3 single-quarter RMB 2.285 billion line, margin balance RMB 2.2 trillion line, degree of PB premium convergence).
The engine behind 2026H1 revenue of RMB 16.229 billion (+51.11%) was a volume beta: investment-related income (investment income + fair-value changes) of RMB 8.028 billion, 49.5% of revenue; brokerage net income of RMB 5.040 billion (+50.7%) relied on the record first-half daily average stock-and-fund turnover of RMB 3.25 trillion (+98.55%). With margin financing down about 19% from its peak and September average daily turnover -15.7% MoM, a lower volume equilibrium will pressure brokerage, margin, and proprietary trading lines simultaneously. We forecast 2026 net profit attributable to parent of RMB 12.4–13.4 billion, falling to RMB 11.0–12.4 billion in 2027 — to be clear, the direction of the 2027 decline is broadly aligned with sell-side consensus (EPS RMB 1.60, approx. RMB 12.4 billion, -1.8%), making it consensus rather than a unique expectation gap; our difference is only in the magnitude of the decline. Current TTM net profit attributable to parent of RMB 12.569 billion (approx. RMB 11.53 billion on a common-share basis) is about 1.4–1.6x the through-cycle common-share earnings center recalculated at current capital scale (approx. RMB 7.0–8.2 billion). Reverse scenario: if margin financing recovers above RMB 2.8 trillion and daily turnover holds above RMB 2.6 trillion, the cyclical-high continuation assumption returns and this thesis fails.
The current price of RMB 22.25 corresponds to 1.97x PB excluding perpetuals and 1.37x on an LF basis including perpetuals; versus the median PB of four large brokerages of 0.955x (median of CITIC 1.22 / Guotai Haitong 0.84 / Huatai 0.87 / Galaxy 1.04, 2026-10-28), that is a premium of about 44% (including perpetuals, same basis) to 106% (excluding perpetuals). PB-ROE reverse solving (r=10.5%, g=3.5%–4%) shows the current price implies a sustainable common-share ROE of about 16.8%–17.3%, whereas the company's through-cycle ROE center is about 8.5%–10% (FY2023 approx. 7.4% / FY2024 8.22% / FY2025 10.51% (estimated)) and industry normalization is only 7%–8% — the current price essentially perpetuates the annualized ROE of the 2026 bull year (approx. 16.7%). Zero-growth EPV is about RMB 8.6–10.1 per share (normalized common net profit of RMB 7.0–8.2 billion ÷ cost of equity 10.5%), covering only about 40% of the current price. Counter-evidence that must also be presented: the stock's own PB sits at about the 1st percentile of the past 5 years (net assets have kept thickening via retained earnings and perpetual bond issuance, distorting the longitudinal percentile), and since listing it has never been priced at the peer median — the historical premium has long persisted, "convergence to the peer median" has no precedent, and the timing and magnitude of premium convergence are highly uncertain. Overall judgment: overvalued. Base-case fair value RMB 17.4–19.7 (1.5–1.7x PB × 2026E BPS ex-perpetuals of approx. RMB 11.60, anchored to the peer median plus a historical premium band for investment banking share and top-tier ROE); the current price is about 20% above the base-case midpoint. This thesis fails if an official consolidation announcement emerges at the company or major-shareholder level, or if volume stabilizes at RMB 2.4–2.6 trillion and 2027 earnings validate the new equilibrium.
The company is a classic "investment banking specialist + mid-tier full-service house": FY2025 revenue of RMB 23.322 billion is about 31% of CITIC Securities', but it firmly ranks in the investment banking top tier with a traditional bond-underwriting strength; FY2025 weighted ROE of 10.51% (estimated) exceeds CICC (9.39%) and most top-tier peers; the two state-owned shareholders together hold 66.6% (the company discloses no controlling shareholder and no de facto controller), full float with no unlock batches, overall pledge ratio of only 2.96%, and no concentrated selling by major shareholders or executives in the past 12 months; the payout ratio is rising with normalized interim dividends (FY2025 full-year RMB 2.637 billion, 31.24% (estimate: 26.37/84.41); 2026 interim proposed RMB 2.249 billion (estimate: RMB 0.29/share × 7.757 billion shares), 31.67%, targeted for payment before Spring Festival). Weaknesses are equally clear: small scale (total assets RMB 860.451 billion, less than 40% of Guotai Haitong's); brokerage revenue elasticity persistently lags the market (FY2025 brokerage +37.0% vs. market turnover +70.34%; 2026H1 +50.7% vs. +98.55%), industry net commission rates have fallen to 0.0171%, with share and commission rate both under pressure. This thesis fails if monthly IPO underwriting share falls sharply or the firm receives a business-suspension-level investment banking penalty.
The market worries that Q3 results will replicate a CITIC-Securities-style single-quarter -20%, but the company has a unique Q3 buffer: joint sponsorship fees from ChangXin Technology's July 27 listing (approx. RMB 110 million per firm at most, limited contribution) and, more importantly, STAR Market follow-on investment paper gains (2% allocation, 24-month lock-up; fair-value appreciation during post-listing price strength directly boosts quarterly P&L). Threshold calculation: 2026Q3 single-quarter ≥ RMB 2.285 billion (YoY decline ≤11.4%) locks in first-three-quarter cumulative +40%; even if the single quarter replicates -20% (RMB 2.064 billion), the cumulative figure is still about +36.9%, above the industry consensus of +32% — the decline is already partly priced in, with odds skewed to the upside. On the merger/consolidation theme: consolidation rumors circulated twice in 2026, but there is no company-level official announcement of any progress (rumors unconfirmed; the 2020 historical rumor was publicly denied by the relevant parties and drew an exchange inquiry). This report treats it as a low-probability event of about 0.1 — an event option only, not a core-position logic. This thesis fails if Q3 single-quarter profit < RMB 2.285 billion and investment-related income turns YoY negative for the quarter.
Financial investment assets at end-2026H1 were RMB 387.8 billion (estimate: trading 241.06 + other debt 77.57 + other equity instruments 69.20), but the sensitivity base that truly flows through the income statement is approx. RMB 244.1 billion of trading financial assets plus derivatives (FVOCI fair-value volatility goes to equity, affecting profit only via dividends and disposal gains); on this basis, each 1pp decline in annualized proprietary returns drags net profit attributable to parent by approx. RMB 1.8 billion/year. Of 2026H1 investment-related income of RMB 8.028 billion, RMB 4.575 billion was fair-value changes (paper gains), and trading financial assets grew by RMB 54.39 billion in six months — exposure still actively expanding. If volume and proprietary returns fall in tandem (per this report's bear case), 2027 net profit attributable to parent could drop to RMB 8.5–10.5 billion (about -20% to -35% vs. the 2026E midpoint), with the PB premium converging to 1.2–1.4x, implying a share price of RMB 14.5–16.9. This thesis fails if annualized proprietary returns hold above 3% and volume stabilizes.
| Metric | FY2023 | FY2024 (restated) | FY2025 | 2026Q1 | 2026H1 (latest period) |
|---|---|---|---|---|---|
| Revenue (RMB bn) | 20.994 | 19.053 | 23.322 | —* | 16.229 |
| Revenue YoY | — | -9.24% (restated basis) | +22.41% | — | +51.11% |
| Net profit attributable to parent (RMB bn) | 7.034 | 7.224 | 9.439 (estimate: common net profit 8.441 + perpetual bond interest 0.999, summed per annual report notes) | —* | 7.639 |
| Net profit attributable to parent YoY | — | +2.7% | +30.68% | — | +69.44% |
| Adjusted net profit attributable to parent (RMB bn) | — | 7.240 | 9.468 | — | approx. 7.76 (estimate) |
| Weighted average ROE | — | 8.22% | 10.51% (estimated) | 4.02% | 8.27% (half-year) |
| Total assets (RMB bn) | 522.752 | 566.418 | 676.816 | — | 860.451 |
| Net assets attributable to parent (RMB bn, incl. perpetual bonds) | 97.478 | 106.469 | 119.102 | — | 125.742 |
| Net assets per share ex-perpetuals (RMB) | — | — | 10.69 | — | 11.29 |
| Leverage excl. client funds (x) | — | — | 4.21 | 4.38 | 4.75 |
| Net capital (RMB bn, parent) | — | 74.675 (restated) | 79.599 | 78.113 | 83.322 |
| Risk coverage ratio | — | 209.25% | 236.50% | 205.55% | 206.54% |
| Net operating cash flow (RMB bn)† | -20.057 | 29.500 | 83.052 (estimate) | — | 60.831 |
| Cash dividends (RMB bn) | 1.939 | 1.978 | 2.637 | — | Interim proposed 2.249 (estimate: RMB 0.29/share × 7.757 bn shares) |
| Payout ratio (common net profit basis) | — | 32.13% (estimate: 19.78/61.57) | 31.24% (estimate: 26.37/84.41) | — | 31.67% (interim) |
* 2026Q1 revenue and net profit attributable to parent were not verified against source documents in this round and are omitted for now (the Q1 report is cached); the 2026 Q3 report is expected to be disclosed on 10-30/31. † Brokerage operating cash flow includes client brokerage deposits and repo business movements (the FY2025 annual report explicitly states "mainly due to repo business and client brokerage deposit movements"); this line has no earnings-quality implications for brokers and serves only as a liquidity reference. Brokers are financial institutions: gross margin / free cash flow / net debt-EBITDA concepts do not apply and those lines are omitted; FY2025 net margin approx. 40.5%.
Reasons for metric changes (items with YoY ≥ ±20%, all with company explanations):
2026H1 revenue was RMB 16.229 billion (+51.11%), net profit attributable to parent RMB 7.639 billion (+69.44%), weighted ROE 8.27% (+3.17pct YoY) — the best half-year results since 2021. Structurally: brokerage net income of RMB 5.040 billion (+50.7%) benefited from average daily stock/fund turnover of RMB 3.25 trillion (+98.55%), though its growth was only about half the market's; investment banking net income of RMB 1.113 billion (-0.81%), with H1 IPO lead underwriting of only RMB 2.413 billion (-71.5%) — investment banking revenue recognition will only show up in Q3 after CXMT's listing; proprietary trading (investment income + fair value of RMB 8.028 billion, 49.5% of revenue) surged to become the largest profit source; margin financing balance of RMB 108.614 billion (+27.61% vs. start of year, 3.60% market share), with 2.0265 million new accounts opened (+143.9%), showing strong retail momentum. The cost is accelerated balance sheet expansion: total assets +27.13% in half a year, leverage ex-client funds rose to 4.75x, and risk coverage ratio fell from 236.50% at the start of the year to 206.54%. Versus market expectations: Soochow Securities (2026-08-19) forecast full-year net profit attributable to parent of RMB 13.36 billion; the interim report has already delivered 57% of that. Industry sell-side consensus for the first three quarters is net profit +30%-32%; the company's H1 growth (+69.44%) is significantly above the industry average (listed brokers' H1 net profit +49%). Conclusion: the interim report itself represents "high-prosperity delivery" rather than an "earnings beat" — the real test comes in Q3: the magnitude of single-quarter deceleration as trading volumes recede (verification line: single-quarter RMB 2.285 billion).
Business model in brief: a full-license broker with a mix of light and heavy capital. The light-capital line (brokerage + investment banking + asset management, earning fees and management fees) runs in parallel with the heavy-capital line (proprietary trading and market-making + margin financing, earning capital gains and interest); in 2026H1, fee-based (light-capital) revenue accounted for about 45%, down markedly from 56.5% in FY2025 — in a bull market, the heavy-capital line's revenue elasticity is naturally faster, but it also binds earnings more deeply to market direction. Revenue is non-recurring and strongly cyclical: brokerage fluctuates with turnover, investment banking with policy cadence, proprietary trading with market conditions; the company has no independent pricing power over any of the three lines (commission rates in a one-way industry-wide decline to 1.71 bps).
Cash content of earnings (financial-sector lens): brokers' operating cash flow swings violently with client fund inflows/outflows (FY2023 -20.057 billion → FY2025 +83.052 billion, estimated); the OCF/net profit ratio has no conventional interpretive value. The correct measure of a broker's earnings quality is capital consumption of earnings and regulatory capital adequacy: leverage ex-client funds of 4.75x (end-2026H1), net capital of RMB 83.322 billion, risk coverage ratio of 206.54%, capital leverage ratio of 14.17% — all with a buffer above regulatory warning lines, but the risk coverage ratio fell 29.96pct in six months — heavy-capital expansion is accelerating capital consumption. Recurring earnings test: the gap between adjusted and reported net profit is minimal (FY2025: RMB 9.468 billion vs. RMB 9.439 billion (estimated, = 8.441 billion common equity profit + 0.999 billion perpetual bond interest); 2026H1: ~RMB 7.76 billion (estimated) vs. RMB 7.639 billion); no one-off gains window-dressing. However, note that annual interest of ~RMB 1 billion on RMB 40.545 billion of perpetual bonds is borne continuously by common shareholders — only ~89% of net profit attributable to parent accrues to common shareholders (FY2025 common equity profit RMB 8.441 billion); EPS and ROE on a common-equity basis are already discounted by ~10%.
Return on capital: FY2025 weighted ROE 10.51%, FY2024 8.22%, 2026H1 annualized ~13%-14% (bull-market year), through-cycle midpoint ~8.5%-10% — above the industry's normalized level (7%-8%); the franchise value of investment banking and institutional businesses constitutes a genuine moat; but a considerable portion of the current ROE comes from proprietary leverage amplification, with clearly stratified quality.
Capex quality (financial-sector replacement lens — risk capital deployment): in 2026H1, trading financial assets rose by RMB 54.39 billion (+29.1%) in six months to RMB 241.06 billion; other equity instruments (FVOCI equity pool) stacked up from RMB 14.8 billion to RMB 69.2 billion within a year — deployment clearly points to financial investment balance-sheet expansion, not light-business capability building; incremental capital returns depend on market conditions, making this "pro-cyclical deployment."
Moat and quality red flags: moat = investment banking license and sponsor team + sci-tech project pipeline + dual-SOE shareholder credit + top-tier institutional client network. Three red flags: ① rising dependence of earnings on proprietary trading (2026H1 investment-type revenue at 49.5% of revenue, highly elastic to market reversals); ② continuous expansion of perpetual bonds eroding common equity returns (FY2025 issuance of RMB 11.3 billion, another RMB 4.4 billion in 2026Q1, outstanding balance RMB 40.545 billion); ③ brokerage revenue elasticity persistently lagging market turnover (share/commission rate pressure, unexplained by the company).
Consistency of words and deeds: pragmatic (based on three verifiable commitment-delivery pairs). ① Dividend cadence commitment: management's investor Q&A of 2025-09-24 pledged "multiple dividends per year starting from FY2024, and to push for interim dividends to be paid before Spring Festival" — the 2025 interim dividend was paid in January 2026, and the 2026 interim dividend proposal (RMB 2.249 billion, estimated) has passed the board and awaits the shareholders' meeting: delivered; ② Stock pledge reduction: the 2024 annual report pledged "prudent conduct of stock pledge repo business" — on-balance-sheet pledge principal reduced from RMB 3.685 billion (end-FY2024) to RMB 1.948 billion (end-2026H1), with collateral coverage ratio rising to 345.25%: delivered; ③ Investment banking standing commitment: the 2024 annual report pledged "consolidating a leading position in the equity financing market" — FY2025 A-share equity financing ranked No. 3 in the industry, M&A restructuring deals No. 1, and IPO underwriting rose to No. 2 in the industry in the first three quarters of 2026: delivered. It should be noted that the company's annual report outlooks are all qualitative with no quantitative guidance, so the falsifiability of commitments is inherently weak.
Shareholder friendliness: neutral to friendly. Absolute dividends and payout ratio rising continuously (FY2023 RMB 1.939 billion → FY2025 RMB 2.637 billion, 31.24% (estimated: 2.637/8.441 on common equity profit basis); 2026 interim RMB 2.249 billion (estimated: RMB 0.29/share × 7.757 billion shares), 31.67%); cumulative dividends since listing will reach RMB 22.725 billion; no equity refinancing record (the 2019 private placement proposal was terminated), no buybacks. Deductions: shareholder returns are pursued via a "dividends + perpetual bond balance-sheet expansion" combination; the RMB 40.5 billion perpetual bond balance erodes common EPS by ~RMB 0.13/share annualized; on the H-share 65% discount and buyback questions repeatedly raised by investors, the company only responds that it will "comprehensively study various market value management tools" — no commitment, no roadmap.
Risk signals: a governance structure with no controlling shareholder and no actual controller (two SOEs at 66.6% + CITIC-related entities ~9.5% combined) — stable but makes consolidation expectations a perpetual narrative source; non-executive director Yang Dong resigned on 2026-07-24 due to work reasons (routine personnel change); since 2024, investment banking and internal-control regulatory penalties have been continuous (see E4 and Chapter 10); regulatory rating pressure warrants ongoing observation.
Per the company's reporting structure, four segments (2026 interim report MD&A "Main business by industry"):
| Segment | 2026H1 revenue share | 2026H1 gross margin | 2026H1 YoY | FY2025 share | One-line business logic |
|---|---|---|---|---|---|
| Trading & institutional client services | 55.9% | 74.22% (+13.75pct) | +94.12% | 41.7% | Proprietary + market-making + derivatives + PB; strongest market β, main profit engine |
| Wealth management | 28.8% | 46.54% | +26.83% | 35.2% | Brokerage + margin financing + distribution; driven by market turnover |
| Investment banking | 6.9% | 19.20% (+3.14pct) | -0.86% | 13.4% | Equity/bond underwriting + M&A advisory; policy-cycle sensitive |
| Asset management | 5.6% | 63.15% (+8.94pct) | +41.14% | 6.1% | Brokerage AUM RMB 625.6 billion + public funds RMB 172.7 billion + PE RMB 82.4 billion |
The profit engine is trading & institutional client services (55.9% revenue share × 74.22% gross margin, double first in absolute and relative terms in 2026H1), not investment banking on which the company's brand is built — investment banking accounts for only 6.9% of revenue, with a segment-low 19.20% gross margin. The gap between highest and lowest gross margins is 55pct because the businesses are fundamentally different: the trading segment earns capital spreads (naturally high gross margin after funding costs), while investment banking is a labor-intensive professional service (rigid sponsor team costs). The core contradiction revealed by this structure: the premium the market pays for an "investment banking champion" is currently supported mainly by proprietary β — converting the premium requires an investment banking supercycle to keep delivering large deals (CXMT Holdings, etc.).
Accounting red flags:
Cross-period consistency:
Conclusion: no profit-manipulation-level hard defects found, but "unexplained FVOCI equity pool expansion + non-operating expenses without disclosed detail" — two points of opacity — combined with an earnings structure where fair value changes account for 57% of investment-type income, discount the interpretability of quarterly profit readings. This is precisely why this report sets dual thresholds for the Q3 report (Oct 30) — "single-quarter RMB 2.285 billion + direction of investment-type income" — rather than looking at net profit alone.
Current market data and multiples (all frozen at the 2026-10-28 close): share price RMB 22.25, total market cap ~RMB 172.6 billion (estimated: 22.25 × 7.757 billion shares); PB ex-perpetuals 1.97x (roughly 1st percentile over its own past 5 years — vertical percentiles are distorted by continuously thickening net assets, for reference only), PB(LF) incl. perpetuals 1.37x; PE(TTM) 13.73x (TTM net profit attributable to parent of RMB 12.569 billion is at a cyclical high, so PE percentile has no discriminating power, reference only); 2026E forward PE ~13.4x (at this report's midpoint forecast of RMB 12.9 billion), 2027E ~15.0x (RMB 11.5 billion). Dividend yield: TTM ~1.5%; based on estimated 2026 full-year DPS of ~RMB 0.50, ~2.2%.
Market-implied expectations: backing out the PB-ROE framework (r=10.5%, g=3.5%-4%), the current ex-perpetual PB of 1.97x implies the market believes sustainable common-equity ROE is ~16.8%-17.3%, corresponding to common-equity earnings of ~RMB 11.2-11.5 billion/year — the current price requires the company to sustain the annualized ROE of the 2026 bull year (~16.7%) forever, whereas reality is a through-cycle midpoint of RMB 7.0-8.2 billion (common equity basis) and industry normalization of 7%-8%. Supporting evidence: the turnover center has indeed risen systematically (2026 first-three-quarters A-share total turnover of RMB 46.548 trillion already exceeded full-year 2025; margin financing peak broke RMB 3 trillion for the first time; client margin at RMB 4.45 trillion). Counterevidence: margin financing -19% from peak, September turnover -15.7% MoM, sell-side consensus for 2027E already turned negative — the first pillar of implied expectations is weakening at the margin. The most honest comparison is the H-shares: same asset at 0.80x PB, ~60% discount; the offshore market pays almost nothing for "perpetualized bull market + consolidation option."
Three-layer value (EPV): asset value (ex-perpetual net assets per share) RMB 11.29 — a book reference including the operating franchise; a floor, not a margin of safety. EPV zero-growth value ~RMB 8.6-10.1/share (normalized common-equity profit of RMB 7.0-8.2 billion, base period FY2023-2026H1 actual earnings and current RMB 85.2 billion common equity, deducting perpetual bond interest, ÷ cost of equity 10.5%); the gap between current price and EPV is ~RMB 12.9/share, ~58% of the current price — the market is paying more than half the current price for "turnover normalization persistence + investment banking supercycle + consolidation option"; this portion is not proven growth value, and its persistence depends on the durability of bull-market turnover (note: ~58% is a high share; the framing "the market prices only zero growth" cannot be applied). The asset layer and EPV are independent references and must not be added together.
Three scenarios and odds (6-12 months, price anchor RMB 22.25 / 2026-10-28):
| Scenario | Probability | Fair range | vs. current price | Decisive factors |
|---|---|---|---|---|
| Bear | 30% | RMB 14.5-16.2 (midpoint 15.35) | -31.0% (to midpoint) | Sustained volume decline (daily avg <RMB 2 trillion, margin <RMB 2.2 trillion) + proprietary return <2% + consolidation theme fading; 2027E net profit attributable RMB 9.5-10.5 billion; PB 1.25-1.40x |
| Base | 50% | RMB 17.4-19.7 (midpoint 18.55) | -16.6% (to midpoint) | Gradual cooling from highs (turnover ≥RMB 2.2 trillion, margin around RMB 2.4 trillion); 2026 net profit attributable RMB 12.4-13.4 billion → 2027E RMB 11.0-12.4 billion, ROE ~11.4%; PB 1.5-1.7x |
| Bull | 20% | RMB 24.6-26.9 (midpoint 25.75) | +15.7% (to midpoint) | Policy bull market continues (turnover ≥RMB 2.6 trillion, margin recovering to RMB 2.8 trillion+) + consolidation expectations ferment + sustained investment banking mega-deals; 2027E RMB 14.0-15.0 billion; PB 2.1-2.3x |
Probability-weighted fair value is RMB 19.03, expected return ~-14.5%; the current price sits precisely between the top of the base range and the bottom of the bull range — the market is effectively assigning ~50% weight to the bull scenario materializing, while hard volume data better supports below-base. Anchoring rationale for the base-scenario exit multiple of 1.5-1.7x PB: large-peer median of 0.955x (2026-10-28) plus the historical premium band from the company's investment banking share and first-tier ROE (its own 1-year median of ~2.27x as the upper reference; Gordon model with ROE 11.7%/r 10.5%/g 4.5% solving to ~1.2x as the lower cross-check); the bull case of 2.1-2.3x is anchored to CICC's 2.29x after its three-way merger settlement (a realized sample of similar "theme premium"). Own earnings forecast vs. consensus vs. management: no quantitative company guidance (management qualitative stance: proprietary equity trading "adheres to an absolute return positioning"; interim dividends paid before Spring Festival); this report's 2026E net profit attributable of RMB 12.4-13.4 billion is 2%-9% below sell-side consensus (~RMB 13.68 billion), and 2027E of RMB 11.0-12.4 billion is 8%-18% below the street (~RMB 13.4 billion) — the divergence centers on the slope of volume cooling from Q4 onward; the offshore 12-month aggregate target price mean of RMB 30.80 (+38%, only 3 analysts) points the opposite way, a significant multi-anchor divergence.
Valuation conclusion: overvalued (relative to base-case fair value). Target price range RMB 17.4-19.7 = base-scenario fair value; margin of safety -21.8% (base-case fair value floor of RMB 17.4 is 21.8% below the current price, a negative value). Quality and price are assessed separately: quality is first-rate, but the price already fully capitalizes both cyclical-peak earnings and the consolidation option.
Industry size: China's securities industry is a capital markets service sector composed of 150 licensed brokerages, with its scale tightly bound to market activity. Per the Securities Association of China: for FY2025, industry-wide operating revenue was RMB 541.171 billion and net profit RMB 219.439 billion (total assets RMB 14.83 trillion, net assets RMB 3.34 trillion); for H1 2026, revenue was RMB 329.810 billion (+31.38%), net profit RMB 138.664 billion (+23.50%), total assets RMB 17.23 trillion, and client trading settlement funds RMB 4.45 trillion (as of 2026-06-30) — meaning H1 alone delivered 63% of FY2025's full-year profit. The industry has shown a V-shape over the past three years: 2024 revenue of roughly RMB 438.0 billion (+8.0%) and net profit of roughly RMB 159.8 billion; after the policy pivot in September 2024, conditions recovered, with 2025 net profit +31.2%, the highest since 2016 (the 43 listed brokerages' combined attributable net profit for 2025 was RMB 212.8 billion, +43.75%, per Soochow Securities statistics). Empirical evidence on earnings elasticity: 2025 A-share total turnover of RMB 41.986 quadrillion (+63.36%) corresponded to industry net profit +31.2%, an elasticity of roughly 0.5; in 2026H1, average daily turnover of RMB 2.73–3.25 trillion (+97%) corresponded to listed brokers' net profit +49% — volume growth is the primary driver, partially offset by declining commission rates.
Value chain and profit distribution: The institutional upstream consists of the CSRC and the exchanges (granting licenses, controlling the pace of IPO/refinancing and margin financing supply, setting commission and risk-control rules — brokers have weak bargaining power against the upstream); the funding upstream is interbank and exchange-based financing (top AAA-rated brokers have the lowest funding costs, giving them a cost advantage in balance-sheet expansion for proprietary trading); brokers occupy the core midstream position; the downstream comprises retail investors (commissions/interest/distribution), institutional investors (PB prime brokerage/custody/trading), and corporate clients (underwriting and sponsorship/financial advisory). Profit currently pools mainly in two lines: capital-intensive businesses (proprietary trading + margin financing, about 46% of industry revenue in 2026H1, with proprietary trading the largest revenue source) and licensed-channel businesses (brokerage + investment banking). CSC Financial has strong bargaining power over downstream corporate clients (scarce IPO projects) but weak bargaining power on the retail side (commission rates declining passively).
Supply-demand and competitive landscape: Three key demand indicators — average daily stock/fund turnover (2026Q3 roughly RMB 2.77 trillion, +10.1% YoY, -17.9% QoQ; first-three-quarter A-share total turnover of RMB 46.548 quadrillion already exceeds all of 2025), margin financing balance (first-ever breach of RMB 3 trillion on 2026-06-23 → pulled back to RMB 2.46 trillion by 10-22, roughly -19%), and IPO/refinancing (123 IPOs in the first three quarters, raising RMB 216.3 billion, +179.8%, exceeding all of 2025). The supply side consists of 150 license-restricted brokerages; capacity expansion occurs through mergers among leaders rather than new entrants: the Guotai Haitong merger (completed in 2025, total assets of RMB 2.26 trillion, industry No. 1), and CICC's share-swap absorption of Dongxing and China Xinda (settlement completed 2026-10-26; post-merger total assets exceeded RMB 1 trillion, jumping to No. 3), forming a "two superpowers, many strong players" landscape. Concentration: in 2025, the top 10 brokerages accounted for 67% of industry revenue and 70% of net profit (per 21st Century Business Herald). Entry barriers: licenses (new issuance frozen), net capital (risk-control metrics directly cap business scale), sponsor teams and project pipelines, and institutional channel networks. Competitive intensity: a persistent commission price war on the brokerage side (industry net commission rate: 2.4 bps in 2024 → ~2.0 bps in 2025 → 1.71 bps in 2026H1); a major reshuffle of IPO rankings in 2026 on the investment banking side (CICC, CSC Financial, and CITIC Securities in the top three); homogenized leveraged proprietary trading with converging performance volatility. Substitution threats: bank wealth-management subsidiaries and public/private funds siphoning wealth-management demand; internet platforms (East Money/THS) diverting retail trading entry points; HK/US-stock brokers diverting cross-border demand.
Cycle and regulation: The industry is in a "high level, marginally cooling" phase — 2026H1 was a bumper earnings period, but from Q3 both turnover and margin balance pulled back from peaks, with only IPOs still rising. Leading indicators: average daily stock/fund turnover, weekly margin balance data, IPO underwriting volume and approval pace, commission rates, and brokerage sector PB percentile. Regulatory direction is neutral-to-positive: the "Six M&A Measures" and new restructuring rules amplify M&A financial advisory business; the six-ministry Implementation Plan for Promoting Long-Term Capital Entry into Markets (2025-01) thickens the base of turnover and institutional business; the STAR Market "1+6" and ChiNext reforms open up IPO supply from tech companies; and consolidation among leaders has regulatory backing. The negative is structural fee-rate decline (public fund fee and commission cuts, market-based net commission rates, underwriting fee competition) — irreversible, so industry excess returns can only be offset through share concentration and asset-light transformation.
Peer benchmarking (as of 2026-10-28 close, FY2025/2026H1 disclosures):
| Company | FY2025 Revenue / Attributable Net Profit (RMB 100mn) | FY2025 Growth | ROE | PB (LF) | Market Cap (RMB 100mn) | Key Differentiator |
|---|---|---|---|---|---|---|
| CITIC Securities | 748.54 / 300.76 | +28.79% / ~+30% | 7.81% for 2026H1 alone | 1.22 | ~3,685 | All-around champion; 3.2x CSC's size |
| Guotai Haitong | 631.07 / 278.09 (incl. negative goodwill) | +87.4% | Boosted by one-offs | 0.84 | ~2,559 | Merged mega-broker; lowest PB |
| Huatai Securities | 358.10 / 163.83 | +6.83% (lagging) | — | 0.87 | ~1,560 | Benchmark in wealth management + fintech |
| CICC | 284.81 / 97.91 | +33.50% | 9.39% | 2.29 | ~2,399 | Institutional investment banking benchmark after three-way merger; also a thematic premium sample |
| China Galaxy | 283.02 / 125.20 | +24.34% | 6.0% for 2026H1 alone | 1.04 | ~1,165 | Deep retail brokerage network; investment banking weak spot |
| CSC Financial | 233.22 / 94.39 (est.) | +22.41% / +30.68% | 10.51% (est.) | 1.37 (incl. AT1) / 1.97 (excl. AT1) | ~1,726 (est.) | Investment banking champion; leading ROE; smallest scale |
Industry positioning: A "single-discipline champion" among leaders — ranked 7th–10th overall (revenue is 31% of CITIC Securities'), but firmly first-tier and gaining share in investment banking (first-three-quarter 2026 IPO underwriting volume rose from industry No. 3 for full-year 2025 to No. 2, driven by major tech deals such as CXMT), with debt underwriting as a traditional strength (industry No. 2 in FY2025, No. 3 in 2026H1); ROE in the top first tier among leaders (10.51% (est.) vs. CICC's 9.39%); share trends: rising in investment banking, stable in brokerage, weaker in asset management. On the "CITIC merger" narrative: CSC Financial and CITIC Securities have no equity affiliation (CITIC Securities' controlling shareholder is CITIC Financial Holdings; CITIC Securities + CITIC Financial Holdings together hold ~9.5% of CSC as a financial investment); CSC's controlling shareholder is Beijing Financial Holdings, with Huijin as the second-largest shareholder, so cross-system consolidation would require coordination between Beijing and Huijin; no official consolidation progress has been disclosed within 2026 — this theme is purely a market-speculation narrative, but each round of industry M&A news acts as a β amplifier for the stock (historical elasticity can be verified in the single-day +8.88% A-share move on the 2020-04-14 rumor).
The decisive factors for brokers lie not in conventional financial frameworks but in the mapping of "five business lines × three market variables." Variable 1: average daily stock/fund turnover — directly determines brokerage revenue (elasticity estimate: each RMB 1 trillion of daily turnover contributes roughly RMB 1.55 billion of the company's net brokerage revenue per half-year); trajectory: 2026H1 daily average of RMB 3.25 trillion (+98.55%) → Q3 RMB 2.77 trillion (-17.9% QoQ) → September RMB 2.29 trillion (-15.7% QoQ). Variable 2: margin financing balance — determines interest income and credit-business risk (company margin balance of RMB 108.614 billion, 3.60% market share; a financing rate of ~6% implies ~RMB 6.5 billion of annual interest income); trajectory: peak of RMB 3.03 trillion on 6-23 → market-wide RMB 2.46 trillion by 10-22 (-19%), with the company's margin balance shrinking along with the industry. Variable 3: IPO/refinancing pace — determines investment banking revenue (market-wide IPOs +179.8% in the first three quarters of 2026; company underwriting share 17.39%, ranked No. 2; 38 IPOs in review pipeline, industry No. 3, with CXMT Holding's RMB 33 billion filing having received inquiries). All three variables are at historically high levels, but the first two have already pulled back — this is the entire data foundation of this report's "cycle peak, marginally cooling" judgment.
Volume-price decomposition by business line (2026H1): Net brokerage revenue of RMB 5.040 billion = volume (daily average turnover of RMB 3.25 trillion) × price (industry net commission rate down to 1.71 bps) — the company's revenue growth (+50.7%) persistently trails volume growth (+98.55%), with dual erosion from price and share; investment banking net revenue of RMB 1.113 billion (-0.81%): debt underwriting of RMB 834.2 billion (industry No. 3) provided support while equity underwriting of RMB 2.413 billion (-71.5%) dragged, with large deals such as CXMT beginning to fill in from Q3; proprietary trading = RMB 244.1 billion P&L exposure × annualized return (H1 ~4.1%, of which 57% was fair-value mark-to-market gains) — a direct function of market direction; asset management AUM of RMB 625.575 billion (+28.92%) plus public funds of RMB 172.696 billion, with management fees rising slowly along with AUM.
Regulatory capital constraints: The other lifeline for brokers is net capital — risk coverage ratio 206.54% (warning line 120%), capital leverage ratio 14.17% (warning line 9.6%), proprietary equity/net capital 24.66%, proprietary non-equity/net capital 330.30%. Balance-sheet expansion is hard-constrained by these: if extrapolated linearly at the 2026H1 depletion pace, the risk coverage ratio would fall to ~170% by mid-2027, forcing the proprietary trading expansion engine to decelerate — under the dual pressure of "volume decline + capital constraints," capital-intensive revenue will naturally slow in 2027. Conclusion: to track this stock, watch margin balance and turnover weekly, IPO underwriting share monthly, and risk coverage ratio plus proprietary returns quarterly — these four numbers signal direction ahead of any annual-report narrative.
Overall rating: Neutral (avoid pending pullback), confidence 0.52, time horizon 6–12 months. The company's quality and industry position are impeccable (C3, confidence 0.85), but the current price embeds excessively high expectations (C2): an implied sustainable ROE of ~17% vs. a cycle-spanning 8.5%–10%; the 60% H-share discount represents a more conservative price for the same asset; volume decline has begun while the 2027 earnings downturn has not yet been priced in (C1). The current price sits ~20% above the base-case fair range, with asymmetric odds skewed downward (-16.6% to base-case midpoint, -31.0% to bear-case midpoint, +15.7% to bull-case midpoint). Strategy: Existing holders may hold and watch the Q3 report and volume confirmation; new positions at the current price are not advised — wait for one of two signals: the stock pulling back into the RMB 17.4–19.7 base-case fair range (valuation reversion), or margin balance recovering above RMB 2.8 trillion with daily turnover holding above RMB 2.6 trillion (bull-case confirmation). Risk disclosure: The biggest weakness of this call is the historical persistence of the premium — the stock has never traded at the peer-median valuation since listing; if consolidation expectations reignite, the premium could first expand toward the bull scenario rather than converge to the base case. Second, if Q3 results beat expectations (mark-to-market follow-on gains realized + single-quarter net profit ≥ RMB 2.58 billion), the deceleration judgment would be temporarily falsified.
Tracking checklist (conditions and thresholds): ① 10-30 Q3 report: whether single-quarter attributable net profit ≥ RMB 2.285 billion, direction of investment-related revenue for the quarter, whether the risk coverage ratio falls below 180%; ② weekly volume metrics: margin balance below RMB 2.2 trillion (bear-case confirmation) or recovering above RMB 2.8 trillion (bull-case confirmation); ③ interim dividend implementation and EGM in Nov–Dec; ④ the December Central Economic Work Conference's statements on capital markets and long-term capital; ⑤ progress of CXMT Holding's IPO review (issuance window 2027Q1–Q2); ⑥ 2027-03 annual report: full-year attributable profit vs. the RMB 12.4 billion forecast floor, whether the payout ratio rises to 30%+; ⑦ any announcement of equity changes at the major-shareholder level (consolidation expectations confirmed or falsified).
This report is based on publicly available information; the price anchor is the 2026-10-28 close of RMB 22.25. All forecasts are analyst judgments and do not constitute investment advice.